CFTR and myocardial infarction: SOX9 has already been reported to promote CF proliferation and migration in vitro (36), and accordingly, both full body SOX9-deficient and CF-specific SOX9-deficient mice had attenuated cardiac dysfunction and fibrosis after myocardial infarction (35, 36).